Works matching IS 00316970 AND DT 2019 AND VI 75 AND IP 2


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials

    Published in:
    European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 207, doi. 10.1007/s00228-018-2566-6
    By:
    • Shuster, Diana L.;
    • Menon, Rajeev M.;
    • Ding, Bifeng;
    • Khatri, Amit;
    • Li, Hong;
    • Cohen, Eric;
    • Jewett, Melissa;
    • Cohen, Daniel E.;
    • Zha, Jiuhong
    Publication type:
    Article
    16
    17